Cargando…

Utilizing human induced pluripotent stem cells to study atrial arrhythmias in the short QT syndrome

BACKGROUND: Among the monogenic inherited causes of atrial fibrillation is the short QT syndrome (SQTS), a rare channelopathy causing atrial and ventricular arrhythmias. One of the limitations in studying the mechanisms and optimizing treatment of SQTS-related atrial arrhythmias has been the lack of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shiti, Assad, Arbil, Gil, Shaheen, Naim, Huber, Irit, Setter, Noga, Gepstein, Lior
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academic Press 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10589759/ https://www.ncbi.nlm.nih.gov/pubmed/37579942 http://dx.doi.org/10.1016/j.yjmcc.2023.08.003

Ejemplares similares

Human Induced Pluripotent Stem Cell-Derived Cardiac Cell Sheets Expressing Genetically Encoded Voltage Indicator for Pharmacological and Arrhythmia Studies
por: Shaheen, Naim, et al.
Publicado: (2018)

Generating ring-shaped engineered heart tissues from ventricular and atrial human pluripotent stem cell-derived cardiomyocytes
por: Goldfracht, Idit, et al.
Publicado: (2020)

Optogenetic modulation of cardiac action potential properties may prevent arrhythmogenesis in short and long QT syndromes
por: Gruber, Amit, et al.
Publicado: (2021)

Reply to ‘Are atrial human pluripotent stem cell-derived cardiomyocytes ready to identify drugs that beat atrial fibrillation?’
por: Shiti, Assad, et al.
Publicado: (2021)

Monitoring Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes with Genetically Encoded Calcium and Voltage Fluorescent Reporters
por: Shinnawi, Rami, et al.
Publicado: (2015)

Optogenetic Control of Human Induced Pluripotent Stem Cell‐Derived Cardiac Tissue Models
por: Gruber, Amit, et al.
Publicado: (2022)

Single-Cell Mechanical Analysis of Human Pluripotent Stem Cell-Derived Cardiomyocytes for Drug Testing and Pathophysiological Studies
por: Ballan, Nimer, et al.
Publicado: (2020)

Calcium Handling in Human Induced Pluripotent Stem Cell Derived Cardiomyocytes
por: Itzhaki, Ilanit, et al.
Publicado: (2011)

QT prolongation-related ventricular arrhythmia associated with atrial fibrillation electrical cardioversion
por: Rav Acha, M, et al.
Publicado: (2023)

Gene- and variant-specific efficacy of serum/glucocorticoid-regulated kinase 1 inhibition in long QT syndrome types 1 and 2
por: Giannetti, Federica, et al.
Publicado: (2023)

Modeling Short QT Syndrome Using Human‐Induced Pluripotent Stem Cell–Derived Cardiomyocytes
por: El‐Battrawy, Ibrahim, et al.
Publicado: (2018)

shRNAs Targeting a Common KCNQ1 Variant Could Alleviate Long-QT1 Disease Severity by Inhibiting a Mutant Allele
por: Cócera-Ortega, Lucía, et al.
Publicado: (2022)

Development of a robust induced pluripotent stem cell atrial cardiomyocyte differentiation protocol to model atrial arrhythmia
por: Thorpe, Jordan, et al.
Publicado: (2023)

Never Out of the Woods: Onset of Events in Long QT Syndrome Late in Life Provoked by Atrial Arrhythmias
por: Ng, Justin, et al.
Publicado: (2014)

Characterization of the mechanism by which a nonsense variant in RYR2 leads to disordered calcium handling
por: Hopton, Claire, et al.
Publicado: (2022)

Initiation of ventricular arrhythmia in the acquired long QT syndrome
por: Alexander, Cherry, et al.
Publicado: (2022)

Increased Short-Term Variability of the QT Interval in Professional Soccer Players: Possible Implications for Arrhythmia Prediction
por: Lengyel, Csaba, et al.
Publicado: (2011)

Iatrogenic QT Abnormalities and Fatal Arrhythmias: Mechanisms and Clinical Significance
por: Cubeddu, Luigi X
Publicado: (2009)

Autonomic conflict exacerbates long QT associated ventricular arrhythmias
por: Winter, James, et al.
Publicado: (2018)

Important Developments in Long QT Syndrome: Not Only for Arrhythmia Specialists
por: Viskin, Sami
Publicado: (2020)

Short-term variability in QT interval and ventricular arrhythmias induced by dofetilide are dependent on high-frequency autonomic oscillations
por: Champeroux, P, et al.
Publicado: (2015)

The effects of volatile induction and maintenance of anesthesia and selective spinal anesthesia on QT interval, QT dispersion, and arrhythmia incidence
por: Ornek, Ender, et al.
Publicado: (2010)

Purkinje Cells as Sources of Arrhythmias in Long QT Syndrome Type 3
por: Iyer, Vivek, et al.
Publicado: (2015)

Adrenal insufficiency causes life-threatening arrhythmia with prolongation of QT interval
por: Komuro, Jin, et al.
Publicado: (2015)

Base Editing of Human Pluripotent Stem Cells for Modeling Long QT Syndrome
por: Wu, Fujian, et al.
Publicado: (2022)

Modeling Atrial Fibrillation using Human Embryonic Stem Cell-Derived Atrial Tissue
por: Laksman, Zachary, et al.
Publicado: (2017)

Congenital Short QT Syndrome
por: Antzelevitch, Charles, et al.
Publicado: (2004)

Congenital Short QT Syndrome
por: Crotti, Lia, et al.
Publicado: (2010)

Atrial Arrhythmias and the Pandemic
por: Chinitz, Larry A.
Publicado: (2021)

Predicting drug-induced changes in QT interval and arrhythmias: QT-shortening drugs point to gaps in the ICHS7B Guidelines
por: Lu, H R, et al.
Publicado: (2008)

“Thorough QT/QTc in a Dish”: Can Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes Predict Thorough QT Outcomes?
por: Vargas, Hugo M.
Publicado: (2019)

Exercise worsening of electromechanical disturbances: A predictor of arrhythmia in long QT syndrome
por: Charisopoulou, Dafni, et al.
Publicado: (2018)

Exercise worsening of electromechanical disturbances: A predictor of arrhythmia in long QT syndrome
por: Charisopoulou, Dafni, et al.
Publicado: (2019)

R-From-T as a Common Mechanism of Arrhythmia Initiation in Long QT Syndromes
por: Liu, Michael B., et al.
Publicado: (2019)

Myocardial bridging is associated with exercise‐induced ventricular arrhythmia and increases in QT dispersion
por: Nishikii‐Tachibana, Makiko, et al.
Publicado: (2017)

Renal artery denervation prevents ventricular arrhythmias in long QT rabbit models
por: Ton, An Nu-Khanh, et al.
Publicado: (2022)

Short‐Term Variability of the QT Interval Can be Used for the Prediction of Imminent Ventricular Arrhythmias in Patients With Primary Prophylactic Implantable Cardioverter Defibrillators
por: Smoczyńska, Agnieszka, et al.
Publicado: (2020)

Induced pluripotent stem cell derived cardiomyocytes as models for cardiac arrhythmias
por: Hoekstra, Maaike, et al.
Publicado: (2012)

Atrial fibrillation – QT interval and catheter ablation
por: Mann, Linda, et al.
Publicado: (2020)

Antiarrhythmic Effects of Vernakalant in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes from a Patient with Short QT Syndrome Type 1
por: Xu, Qiang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2skf8fbtap8d02j8a2s5depmsf